Hochschulschrift
Eosinophils as biomarker in melanoma immunotherapy and solid tumors
- Sprache
-
Englisch
- Umfang
-
59 Blätter
- Maße
-
30 cm
- Anmerkungen
-
Illustrationen, Diagramme
Enthält 2 Sonderabdrucke
Ruprecht-Karls-Universität Heidelberg, Dissertation, 2021
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Urheber
- Beteiligte Personen und Organisationen
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wann)
-
[2021]
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:27 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Entstanden
- [2021]
Ähnliche Objekte (12)
Immunotherapy of malignant melanoma
Localized immunotherapy with self-amplifying RNA immunotherapy in murine solid tumor models
Identification of tumor-specific peptides for adjuvant immunotherapy of melanoma patients
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Active specific immunotherapy of malignant melanoma with cytokine gene-transduced tumor cell vaccines
Tumor Immunotherapy: Lessons from Autoimmunity
The influence of hypoxia on RIG-I-mediated melanoma immunotherapy
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Immunotherapy of solid tumors: multimodal imaging strategies for chimeric antigen receptor T cell tracking in the tumor microenvironment
The role of tumor derived circulating cell-free RNA as a potential biomarker in melanoma
Optimization of engineered T cells for the use in melanoma immunotherapy
Immunotherapy of malignant melanoma
Localized immunotherapy with self-amplifying RNA immunotherapy in murine solid tumor models
Identification of tumor-specific peptides for adjuvant immunotherapy of melanoma patients
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Active specific immunotherapy of malignant melanoma with cytokine gene-transduced tumor cell vaccines
Tumor Immunotherapy: Lessons from Autoimmunity
The influence of hypoxia on RIG-I-mediated melanoma immunotherapy
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Immunotherapy of solid tumors: multimodal imaging strategies for chimeric antigen receptor T cell tracking in the tumor microenvironment
The role of tumor derived circulating cell-free RNA as a potential biomarker in melanoma
Optimization of engineered T cells for the use in melanoma immunotherapy
Immunotherapy of malignant melanoma
Localized immunotherapy with self-amplifying RNA immunotherapy in murine solid tumor models
Identification of tumor-specific peptides for adjuvant immunotherapy of melanoma patients
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Active specific immunotherapy of malignant melanoma with cytokine gene-transduced tumor cell vaccines
Tumor Immunotherapy: Lessons from Autoimmunity
The influence of hypoxia on RIG-I-mediated melanoma immunotherapy
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Immunotherapy of solid tumors: multimodal imaging strategies for chimeric antigen receptor T cell tracking in the tumor microenvironment
The role of tumor derived circulating cell-free RNA as a potential biomarker in melanoma